Published in Am J Clin Nutr on August 31, 2011
Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ (2014) 7.21
Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study. Osteoporos Int (2012) 4.09
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation. Osteoporos Int (2015) 1.60
Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab (2012) 1.42
Calcium supplements and cardiovascular risk in the Women's Health Initiative. Osteoporos Int (2013) 1.42
Sunlight and Vitamin D: A global perspective for health. Dermatoendocrinol (2013) 1.41
Plasma vitamin D levels, menopause, and risk of breast cancer: dose-response meta-analysis of prospective studies. Medicine (Baltimore) (2013) 1.19
Evidence-based D-bate on health benefits of vitamin D revisited. Dermatoendocrinol (2012) 1.12
Vitamin D - a systematic literature review for the 5th edition of the Nordic Nutrition Recommendations. Food Nutr Res (2013) 1.11
Molecular link between vitamin D and cancer prevention. Nutrients (2013) 1.10
The impact of vitamin D in breast cancer: genomics, pathways, metabolism. Front Physiol (2014) 1.06
Meta-analysis of long-term vitamin D supplementation on overall mortality. PLoS One (2013) 1.03
Differences in vitamin D status may account for unexplained disparities in cancer survival rates between African and white Americans. Dermatoendocrinol (2012) 1.03
Patient education for phosphorus management in chronic kidney disease. Patient Prefer Adherence (2013) 0.99
Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos). J Clin Endocrinol Metab (2013) 0.99
Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J (2013) 0.95
Role of solar UVB irradiance and smoking in cancer as inferred from cancer incidence rates by occupation in Nordic countries. Dermatoendocrinol (2012) 0.94
Optimal Vitamin D Supplementation Doses that Minimize the Risk for Both Low and High Serum 25-Hydroxyvitamin D Concentrations in the General Population. Nutrients (2015) 0.92
Role of calcium, vitamin D, and the extrarenal vitamin D hydroxylases in carcinogenesis. Anticancer Agents Med Chem (2013) 0.90
Errors in NOF meta-analyses of calcium and vitamin D supplements. Osteoporos Int (2016) 0.90
Caution in reinterpreting the Women's Health Initiative (WHI) Calcium and Vitamin D Trial breast cancer results. Am J Clin Nutr (2012) 0.87
Plasma 25-hydroxyvitamin D3 is associated with decreased risk of postmenopausal breast cancer in whites: a nested case-control study in the multiethnic cohort study. BMC Cancer (2014) 0.86
On the roles of solar UV irradiance and smoking on the diagnosis of second cancers after diagnosis of melanoma. Dermatoendocrinol (2012) 0.86
Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria? Dermatoendocrinol (2012) 0.84
The Role of Vitamin D in the Aging Adult. J Aging Gerontol (2014) 0.83
Food Fortification and Supplement Use-Are There Health Implications? Crit Rev Food Sci Nutr (2016) 0.82
Dietary calcium intake and mortality risk from cardiovascular disease and all causes: a meta-analysis of prospective cohort studies. BMC Med (2014) 0.82
Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture, and Stiffness in Primary Hyperparathyroidism. J Clin Endocrinol Metab (2016) 0.80
The pleiotropic effects of vitamin D in gynaecological and obstetric diseases: an overview on a hot topic. Biomed Res Int (2015) 0.80
Associations between serum-intact parathyroid hormone, serum 25-hydroxyvitamin D, oral vitamin D analogs and metabolic syndrome in peritoneal dialysis patients: a multi-center cross-sectional study. Perit Dial Int (2014) 0.80
Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study. Cancer Prev Res (Phila) (2016) 0.80
An ecological study of cancer mortality rates in California, 1950-64, with respect to solar UVB and smoking indices. Dermatoendocrinol (2012) 0.79
The role of geographical ecological studies in identifying diseases linked to UVB exposure and/or vitamin D. Dermatoendocrinol (2016) 0.79
Effect of High-Calcium Diet on Coronary Artery Disease in Ossabaw Miniature Swine With Metabolic Syndrome. J Am Heart Assoc (2015) 0.78
Model selection approach suggests causal association between 25-hydroxyvitamin D and colorectal cancer. PLoS One (2013) 0.78
Vitamin D and colorectal cancer: molecular, epidemiological and clinical evidence. Br J Nutr (2016) 0.78
Skeletal manifestations of treatment of breast cancer. Curr Osteoporos Rep (2013) 0.77
Immune regulatory activity of vitamin d3 in head and neck cancer. Cancers (Basel) (2013) 0.77
Emphasizing the health benefits of vitamin D for those with neurodevelopmental disorders and intellectual disabilities. Nutrients (2015) 0.77
Decreasing 25-hydroxy-vitamin D levels account for portion of the effect of increasing body mass index on breast cancer mortality. Mol Nutr Food Res (2012) 0.77
Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium. Eur J Epidemiol (2015) 0.76
What Do People Know and Believe about Vitamin D? Nutrients (2016) 0.76
CYP2R1 Mutations Impair Generation of 25-hydroxyvitamin D and Cause an Atypical Form of Vitamin D Deficiency. J Clin Endocrinol Metab (2015) 0.76
Estimated economic benefit of increasing 25-hydroxyvitamin D concentrations of Canadians to or above 100 nmol/L. Dermatoendocrinol (2016) 0.75
Vitamin D deficiency is significantly associated with depression in patients with chronic kidney disease. PLoS One (2017) 0.75
Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes. Steroids (2016) 0.75
Vitamin D: Ten Beliefs. J Gen Intern Med (2016) 0.75
Calcium supplements--vascular risks versus bone benefits? Nat Rev Endocrinol (2013) 0.75
Serum Calcium Concentration Is Inversely Associated With Radiographic Knee Osteoarthritis: A Cross-Sectional Study. Medicine (Baltimore) (2016) 0.75
The effect of supplementary calcium on blood pressure in healthy adult women aged 18-30 years in Tehran, Iran. J Educ Health Promot (2015) 0.75
Function of the vitamin D endocrine system in mammary gland and breast cancer. Mol Cell Endocrinol (2017) 0.75
Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One (2017) 0.75
Colonic transcriptional response to 1α,25(OH)2 vitamin D3 in African- and European-Americans. J Steroid Biochem Mol Biol (2017) 0.75
Adrenal disorders: Is there Any role for vitamin D? Rev Endocr Metab Disord (2016) 0.75
Statistics in medicine--reporting of subgroup analyses in clinical trials. N Engl J Med (2007) 12.55
Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ (2010) 10.85
Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet (2000) 9.80
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr (2007) 9.61
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Ann Epidemiol (2003) 8.64
Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med (2007) 7.87
Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63
Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA (1991) 6.05
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05
The role of vitamin D in cancer prevention. Am J Public Health (2005) 4.99
The challenge of subgroup analyses--reporting without distorting. N Engl J Med (2006) 4.19
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst (2008) 3.60
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study Group. Lancet (2000) 3.26
Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol Sci Med Sci (2009) 2.01
Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst (1984) 1.74
Role of bile acids in colorectal carcinogenesis. Eur J Cancer (1995) 1.66
Breast cancer: weighing the evidence for a promoting role of dietary fat. J Natl Cancer Inst (1997) 1.42
Calcium supplementation and cancer incidence. Am J Clin Nutr (2008) 0.83
Artifact in the control group undermines the conclusions of a vitamin D and cancer study. Am J Clin Nutr (2008) 0.82
Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N Engl J Med (2007) 18.27
Denosumab for prevention of fractures in postmenopausal women with osteoporosis. N Engl J Med (2009) 13.57
Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ (2010) 10.85
Genome-wide meta-analysis identifies 56 bone mineral density loci and reveals 14 loci associated with risk of fracture. Nat Genet (2012) 5.48
Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ (2008) 5.14
Paget's disease of bone: an endocrine society clinical practice guideline. J Clin Endocrinol Metab (2014) 4.63
The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 4.15
The peroxisome proliferator-activated receptor-gamma agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab (2007) 4.01
Incidence of osteonecrosis of the jaw in women with postmenopausal osteoporosis in the health outcomes and reduced incidence with zoledronic acid once yearly pivotal fracture trial. J Am Dent Assoc (2008) 2.75
Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res (2015) 2.74
Factors influencing mortality in acromegaly. J Clin Endocrinol Metab (2004) 2.69
Genome-wide association study using extreme truncate selection identifies novel genes affecting bone mineral density and fracture risk. PLoS Genet (2011) 2.34
Vitamin D: a place in the sun? Arch Intern Med (2010) 2.18
Medical management of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.17
Randomized controlled trial of calcium supplementation in healthy, nonosteoporotic, older men. Arch Intern Med (2008) 2.10
Odanacatib in the treatment of postmenopausal women with low bone mineral density: three-year continued therapy and resolution of effect. J Bone Miner Res (2011) 2.07
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure. J Bone Miner Res (2008) 2.04
Discrepancies in predicted fracture risk in elderly people. BMJ (2013) 2.04
Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2012) 1.98
Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures. J Bone Miner Res (2012) 1.92
The effects of seasonal variation of 25-hydroxyvitamin D and fat mass on a diagnosis of vitamin D sufficiency. Am J Clin Nutr (2007) 1.83
Effects of carvedilol on left ventricular remodeling after acute myocardial infarction: the CAPRICORN Echo Substudy. Circulation (2004) 1.80
Acute coronary syndrome care across Australia and New Zealand: the SNAPSHOT ACS study. Med J Aust (2013) 1.69
Effect of osteoporosis treatment on mortality: a meta-analysis. J Clin Endocrinol Metab (2010) 1.68
Decreased bone density in men on methadone maintenance therapy. Addiction (2010) 1.63
Five years of anti-resorptive activity after a single dose of zoledronate--results from a randomized double-blind placebo-controlled trial. Bone (2012) 1.62
Goal-directed treatment of osteoporosis. J Bone Miner Res (2013) 1.58
Calcium supplementation: balancing the cardiovascular risks. Maturitas (2011) 1.56
Skeletal phenotype of the leptin receptor-deficient db/db mouse. J Bone Miner Res (2011) 1.55
Pseudonormal mitral filling pattern predicts hospital re-admission in patients with congestive heart failure. J Am Coll Cardiol (2002) 1.55
WNT16 influences bone mineral density, cortical bone thickness, bone strength, and osteoporotic fracture risk. PLoS Genet (2012) 1.55
Cellular characterization of the gouty tophus: a quantitative analysis. Arthritis Rheum (2010) 1.52
The skeletal effects of the tyrosine kinase inhibitor nilotinib. Bone (2011) 1.50
Association of fat-free mass and training status with left ventricular size and mass in endurance-trained athletes. J Am Coll Cardiol (2004) 1.48
Defining vitamin D deficiency. N Z Med J (2007) 1.45
Abdominal aortic calcification on vertebral morphometry images predicts incident myocardial infarction. J Bone Miner Res (2010) 1.45
Does calcium supplementation increase cardiovascular risk? Clin Endocrinol (Oxf) (2010) 1.44
Should measurement of vitamin D and treatment of vitamin D insufficiency be routine in New Zealand? N Z Med J (2012) 1.42
CLINICAL Review # : low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis. J Clin Endocrinol Metab (2007) 1.42
The randomised controlled trial to meta-analysis ratio: original data versus systematic reviews in the medical literature. N Z Med J (2007) 1.40
Bone metabolism during long-term treatment with imatinib. Leuk Lymphoma (2013) 1.40
Evaluation of the FRAX and Garvan fracture risk calculators in older women. J Bone Miner Res (2011) 1.39
Prolonged antiresorptive activity of zoledronate: a randomized, controlled trial. J Bone Miner Res (2010) 1.37
Enhanced osteoclastogenesis in patients with tophaceous gout: urate crystals promote osteoclast development through interactions with stromal cells. Arthritis Rheum (2008) 1.36
In vitro and in vivo effects of adiponectin on bone. Endocrinology (2009) 1.35
Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J Bone Miner Res (2011) 1.32
A mutation in the gene TNFRSF11B encoding osteoprotegerin causes an idiopathic hyperphosphatasia phenotype. Hum Mol Genet (2002) 1.32
Vitamin D repletion in patients with primary hyperparathyroidism and coexistent vitamin D insufficiency. J Clin Endocrinol Metab (2005) 1.30
General practitioners' and pharmacists' perceptions of the role of community pharmacists in delivering clinical services. Res Social Adm Pharm (2009) 1.28
Modulation of osteoclastogenesis by fatty acids. Endocrinology (2008) 1.25
Fat mass is an important predictor of parathyroid hormone levels in postmenopausal women. Bone (2005) 1.25
Plasma amino-terminal pro-brain natriuretic peptide and accuracy of heart-failure diagnosis in primary care: a randomized, controlled trial. J Am Coll Cardiol (2003) 1.25
In vivo retinal nerve fiber layer thickness measured by optical coherence tomography predicts visual recovery after surgery for parachiasmal tumors. Invest Ophthalmol Vis Sci (2008) 1.24
Pathogenesis and management of Paget's disease of bone. Lancet (2008) 1.21
10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program. Arch Intern Med (2008) 1.20
Three-dimensional assessment of left ventricular systolic strain in patients with type 2 diabetes mellitus, diastolic dysfunction, and normal ejection fraction. Am J Cardiol (2004) 1.18
The effect of 6 versus 9 years of zoledronic acid treatment in osteoporosis: a randomized second extension to the HORIZON-Pivotal Fracture Trial (PFT). J Bone Miner Res (2015) 1.18
Multistage genome-wide association meta-analyses identified two new loci for bone mineral density. Hum Mol Genet (2013) 1.17
Vitamin D insufficiency and health outcomes over 5 y in older women. Am J Clin Nutr (2009) 1.17
Association between primary hyperparathyroidism and increased body weight: a meta-analysis. J Clin Endocrinol Metab (2004) 1.16
Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate. J Bone Miner Res (2007) 1.16
Imatinib promotes osteoblast differentiation by inhibiting PDGFR signaling and inhibits osteoclastogenesis by both direct and stromal cell-dependent mechanisms. J Bone Miner Res (2007) 1.15
The antiresorptive effects of a single dose of zoledronate persist for two years: a randomized, placebo-controlled trial in osteopenic postmenopausal women. J Clin Endocrinol Metab (2008) 1.14
Age-, gender-, and weight-related effects on levels of 25-hydroxyvitamin D are not mediated by vitamin D binding protein. Clin Endocrinol (Oxf) (2007) 1.12
Calcium supplements increase risk of myocardial infarction. J Bone Miner Res (2015) 1.11
Macular thickness predictive of visual field sensitivity in ischaemic optic neuropathy. Acta Ophthalmol (2012) 1.09
Osteonecrosis of the jaw and bisphosphonates--putting the risk in perspective. N Z Med J (2006) 1.09
Strontium and cardiovascular events. Ann Rheum Dis (2013) 1.09
Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years. Clin Endocrinol (Oxf) (2007) 1.08
Determinants of vitamin D status in older women living in a subtropical climate. Osteoporos Int (2005) 1.08
Teriparatide for bone loss in the jaw. N Engl J Med (2010) 1.08
Relationships between vascular calcification, calcium metabolism, bone density, and fractures. J Bone Miner Res (2010) 1.07